Aspen Aerogels
ASPN
29 hedge funds and large institutions have $214M invested in Aspen Aerogels in 2014 Q2 according to their latest regulatory filings, with 29 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
84.27% more ownership
Funds ownership: 0% → 84.27% (+84%)
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$74.3M |
| 2 |
GKFF
George Kaiser Family Foundation
Tulsa,
Oklahoma
|
+$34.4M |
| 3 |
RO
Reservoir Operations
New York
|
+$31.2M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$14.4M |
| 5 |
Barclays
London,
United Kingdom
|
+$11.8M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TRCT
26
Tower Research Capital (TRC)
New York
| $80K | +$78.7K | +7,253 | New |
|
|
MSE
27
MUFG Securities EMEA
London,
United Kingdom
| $55.3K | +$54.2K | +5,000 | New |
|
28
Morgan Stanley
New York
| $14K | +$13.8K | +1,274 | New |
|
29
Citigroup
New York
| – | +$54 | +5 | New |
|
ASPN Hedge Fund Activity: Q2 2014 in Review
29 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Aspen Aerogels (ASPN) for Q2 2014, worth a combined $214M.
Buyers outnumbered sellers: 29 funds opened new ASPN positions and 0 closed out — a net gain of 29 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Fidelity Investments, opening a new position worth an estimated $74.3M.
- 29 institutional investors held Aspen Aerogels (ASPN) as of Q2 2014, up from 0 in Q1 2014.
- Funds reported $214M of Aspen Aerogels stock for Q2 2014.
- 29 funds opened new Aspen Aerogels positions in Q2 2014 and 0 closed out, a net change of +29 holders.
- The largest Aspen Aerogels buyer in Q2 2014 was Fidelity Investments, an estimated $74.3M added.
Based on aggregated 13F filings for Q2 2014.